Edmond DE Rothschild Holding S.A. purchased a new position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the 2nd quarter, HoldingsChannel.com reports. The institutional investor purchased 40,362 shares of the semiconductor company’s stock, valued at approximately $18,004,000.
A number of other institutional investors and hedge funds have also modified their holdings of the business. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in Synopsys in the second quarter valued at about $747,400,000. China Universal Asset Management Co. Ltd. grew its position in shares of Synopsys by 31.8% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 14,810 shares of the semiconductor company’s stock worth $6,957,000 after buying an additional 3,575 shares during the period. Norges Bank bought a new stake in shares of Synopsys in the 4th quarter valued at about $730,197,000. SBI Okasan Asset Management Co.Ltd. bought a new stake in shares of Synopsys in the 4th quarter valued at about $1,699,000. Finally, Atreides Management LP acquired a new stake in shares of Synopsys in the 1st quarter valued at approximately $54,288,000. 85.47% of the stock is owned by institutional investors.
Synopsys Stock Down 0.8%
Shares of Synopsys stock opened at $401.24 on Thursday. The firm has a market cap of $76.83 billion, a PE ratio of 92.88, a P/E/G ratio of 2.38 and a beta of 1.23. The business’s 50 day simple moving average is $422.02 and its 200 day simple moving average is $440.99. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. Synopsys, Inc. has a 52-week low of $366.00 and a 52-week high of $615.79.
Analyst Ratings Changes
Several research firms recently weighed in on SNPS. Rosenblatt Securities lifted their price objective on shares of Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a research note on Tuesday, May 26th. Wells Fargo & Company cut their target price on shares of Synopsys from $535.00 to $450.00 and set an “equal weight” rating on the stock in a report on Tuesday, August 11th. Robert W. Baird set a $558.00 price target on shares of Synopsys in a research report on Thursday, May 28th. Berenberg Bank set a $633.00 price target on shares of Synopsys in a report on Wednesday, May 27th. Finally, Citigroup raised their price objective on Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $563.59.
View Our Latest Research Report on Synopsys
Insider Buying and Selling at Synopsys
In related news, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the transaction, the chief executive officer owned 75,020 shares in the company, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.56% of the company’s stock.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Further Reading
- Five stocks we like better than Synopsys
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
